Prognostic Factors in Patients with Advanced Lung Adenocarcinoma Treated with Icotinib

Prognostic Factors in Patients with Advanced Lung Adenocarcinoma Treated with Icotinib

Objective To investigate the relationship between the treatment of EGFR-TKI icotinib and the prognosis of advanced lung adenocarcinoma patients with EGFR mutation. Methods Patients with advanced lung adenocarcinoma who had EGFR19 and 21 gene mutations and were treated with EGFR-TKI icotinib were enr...

Full description

Bibliographic Details
Main Authors: ZHANG Hongbin, ZHU Lingling, XIE Jiong, CAI Hongmei, JI Qiaoxia, LIANG Xiangcun, LI Hua, WANG Yuan, ZHAO Min
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2022-11-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
lung cancer
egfr
tki
icotinib
neoplasm metastasis
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0174

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0174

Similar Items